прополис对PPP2R1A和癌细胞中亡的作用
Burak Durmaz1,2, Latife Merve Oktay Çelebi3, Ayşe Çekin3
1Department of Medical Biochemistry, Faculty of Medicine, Near East University, Nicosia, Cyprus.
提取物通过增加PPP2R1A水平,癌症治疗中的关键分子,显示出作为癌症治疗的潜力. 这项研究表明, прополис诱导了亡标志物,这表明它是各种癌症的新治疗标.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 药理学 药理学是指药理学的学科.
背景情况:
- 蛋白酸酶2A (PP2A) 功能障碍与许多癌症有关.
- 提取物的精确抗癌机制在很大程度上是未知的.
- PP2A的子单元PP2R1A是癌症治疗的潜在目标.
研究的目的:
- 为了研究 прополис对PPP2R1A表达在结直肠,前列腺和乳腺癌细胞系中的作用.
- 探索治疗,PPP2R1A水平和亡之间的关系.
- 分析 прополис对关键亡标记物的影响,包括TRAIL,APAF-1和caspases.
主要方法:
- 通过LC-MS/MS提取和量化化合物.
- 使用实时细胞分析系统-xCELLigence (RTCA-SP) 评估细胞活力和细胞毒性.
- 在癌症和健康细胞系中分析PPPP2R1A表达和亡标记 (TRAIL,Apaf-1,caspases-3, -8, -9).
主要成果:
- прополис治疗显著增加了SW-620 (结肠直肠癌) 细胞中的caspase-3和TRAIL水平.
- 与健康的纤维细胞相比,PC-3 (前列腺癌) 细胞中观察到caspase-8的显著增加.
- прополис在测试的癌症细胞系中显示出提高PPP2R1A水平和亡标志物的能力.
结论:
- прополис治疗诱导癌细胞的亡,可能通过PPP2R1A的上调调节.
- 醇诱导的PPP2R1A水平升高可能会激活亡途径,呈现出一种新的治疗策略.
- 这项研究确定了石诱导PPPP2R1A水平作为癌症治疗的潜在新标.
更多相关视频
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
04:20Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer
Published on: February 9, 2024
相关概念视频
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
DNA Damage can Stall the Cell Cycle
